亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Anti-Cancer Agents Synthesized Based on Miliusane Compounds

總結
The present invention is in the field of pharmaceuticals and chemical industries. In particular, the present invention relates to new anticancer agents based on the miliusane compounds. The present invention also includes its preparation and application method for treating cancer
技術優勢
Miliusanes compounds with an improved anticancer activity and low in toxicity
技術應用
For use in the treatment, prevention or delay of progression of a cancer, particularly colon cancer, breast cancer, prostate cancer, lung cancer, melanoma, leukemia, brain cancer, renal cancer, ovarian cancer, and oral epidermoid cancer.
詳細技術說明
The present invention relates to anticancer agents which are synthesized based on miliusane. More particularly, the agents are derivatives of the core structures of miliusanes.
附加資料
Patent Number: US9211333B2
Application Number: US13831997A
Inventor: Zhang, Hongjie
Priority Date: 5 Jun 2012
Priority Number: US9211333B2
Application Date: 15 Mar 2013
Publication Date: 15 Dec 2015
IPC Current: A61K004506 | A61K0031343 | A61K00314025 | C07D030794 | C07D040512 | C07D040706 | C07D040912
Assignee Applicant: Hong Kong Baptist University
Title: Anti-cancer agents synthesized based on miliusane compounds
Usefulness: Anti-cancer agents synthesized based on miliusane compounds
Summary: (I) are useful for treating, preventing or delaying progression of a cancer in a subject (human), where the cancer is colon cancer, breast cancer, prostate cancer, lung cancer, melanoma, leukemia, brain cancer, renal cancer, ovarian cancer, and oral epidermoid cancer (all claimed). Test details are described but no results for the compounds of the claims are given.
Novelty: New substituted miliusane derivatives useful for treating cancer e.g. colon cancer, breast cancer, lung cancer, melanoma, leukemia, brain cancer, renal cancer and ovarian cancer in human
主要類別
診斷/治療
細分類別
癌症/腫瘤
申請日期
2013.03.15
申請號碼
US 13/831,997
其他
Filed
ID號碼
A61/ZH/Mili/US01
國家/地區
香港

欲了解更多信息,請點擊 這裡
移動設備